Despite Successful Trials A Significant Population Of The World Won’t Get Covid-19 Vaccine Until 2022

covid-19 vaccine
Via Telegraph India

Almost a quarter of the world’s population will not have access to a Covid-19 vaccine until 2022, according to new research.

Experts from the Johns Hopkins Bloomberg School of Public Health in Baltimore in the US said high-income countries have already secured billions of doses, with uncertainty around access for middle and low-income countries.

Also READ: Pfizer COVID-19 Vaccine Delivers Hope, But Not For Pakistan

Hath Aya Per… Mu Na Laga


Rich countries are rapidly claiming the world’s lion’s share of future doses of COVID-19 vaccine, creating deep inequalities in global distribution.

Despite an international agreement to allocate the vaccine equitably around the world, billions of people in poor and middle-income countries might not be immunized until 2023 or even 2024, researchers at Duke University predict.


Experts warned that, even if manufacturers meet all their production goals, people in poorer countries could face a long wait. Maximum production expected in 2021 is 5.96 billion doses, and people need two doses at minimum.

Rich countries with 14% of population have booked more than half of 2021’s vaccine production. they have booked doses many times their requirement. 1/5th of the world’s population mostly from poor countries will not have access to the vaccine until 2022

Canada, for example, has ordered enough vaccines to protect each Canadian five times, they claim.

Mujhe Canada Jana Hai


The World Health Organization’s (WHO) COVAX program is the main global scheme to vaccinate people in poor and middle-income countries around the world against the coronavirus.

But in internal documents reviewed by Reuters, the scheme’s promoters say the program is struggling from a lack of funds, supply risks and complex contractual arrangements which could make it impossible to achieve its goals.

GIF by

COVAX program aims to deliver at least two billion vaccine doses by the end of 2021 to cover 20 per cent of the most vulnerable people in 91 poor and middle-income countries, mostly in Africa, Asia and Latin America.

Pakistan has also signed up for the program and is relying on it to vaccinate as much as 20 per cent of its population, according to the health ministry.


Do you have something else to add to this story? Write down in the comments below.